Author

Dafna Abelson

Mapp Biopharmaceutical (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:non-human primate· 1

Frequent Co-Authors

Abhishek N. PrasadiD· 1 shared Courtney B. WoolseyiD· 1 shared Daniel J. DeeriD· 1 shared Joan B. Geisbert· 1 shared Kevin MelodyiD· 1 shared Krystle N. AgansiD· 1 shared Lindita Ajazaj BerishaiD· 1 shared Rachel L O'Toole· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Abhishek N. PrasadORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A single-dose recombinant rVSVΔG-CCHFV-GPC vaccine protects nonhuman primates against heterologous Crimean-Congo hemorrhagic fever virus challenge

Robert W. Cross, Kevin Melody, Rachel L O'Toole, Viktoriya Borisevich, Daniel J. Deer, Joan B. Geisbert, Courtney B. Woolsey, Krystle N. Agans, Abhishek N. Prasad, Dafna Abelson, Xhevat R. Jakupi, Lindita Ajazaj Berisha, Salih Ahmeti, Thomas W. Geisbert

This study shows a single dose of a recombinant rVSV vaccine protects nonhuman primates from CCHFV infection, with immune responses similar to human survivors.

bioRxiv · Oct 22, 2026 · PreprintMicrobiology